(Q38045464)

27 August 2017

title

Screening for small molecule inhibitors of Toxoplasma gondii (English)

1 reference

27 August 2017

0 references

Sandhya Kortagere

1

1 reference

27 August 2017

language of work or name

English

0 references

publication date

24 September 2012

1 reference

Expert Opinion on Drug Discovery

27 August 2017

published in

1 reference

27 August 2017

volume

7

1 reference

27 August 2017

issue

12

1 reference

27 August 2017

page(s)

1193-1206

1 reference

Cats and Toxoplasma: implications for public health

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

Toxoplasma gondii: from animals to humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

Genetic divergence of Toxoplasma gondii strains associated with ocular toxoplasmosis, Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

A cell cycle model for the tachyzoite of Toxoplasma gondii using the Herpes simplex virus thymidine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

Parasitic diseases of the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

Mechanisms of Toxoplasma gondii persistence and latency

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

Control of the risk of human toxoplasmosis transmitted by meat

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

Epilepsy and seropositivity rates of Toxocara canis and Toxoplasma gondii

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

The importance of toxoplasma gondii infection in diseases presenting with headaches. Headaches and aseptic meningitis may be manifestations of the Jarisch-Herxheimer reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

Toxoplasma gondii actively inhibits neuronal function in chronically infected mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

Therapy and prophylaxis of systemic protozoan infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

Update on clindamycin in the management of bacterial, fungal and protozoal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

A review of molecular modelling studies of dihydrofolate reductase inhibitors against opportunistic microorganisms and comprehensive evaluation of new models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

Synthesis and biological evaluation of biguanide and dihydrotriazine derivatives as potential inhibitors of dihydrofolate reductase of opportunistic microorganisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

Design, synthesis, biological evaluation and computational investigation of novel inhibitors of dihydrofolate reductase of opportunistic pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

N9-substituted 2,4-diaminoquinazolines: synthesis and biological evaluation of lipophilic inhibitors of pneumocystis carinii and toxoplasma gondii dihydrofolate reductase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

The effect of 5-alkyl modification on the biological activity of pyrrolo[2,3-d]pyrimidine containing classical and nonclassical antifolates as inhibitors of dihydrofolate reductase and as antitumor and/or antiopportunistic infection agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

Synthesis of 2,4-diamino-6-[2'-O-(omega-carboxyalkyl)oxydibenz[b,f]azepin-5-yl]methylpteridines as potent and selective inhibitors of Pneumocystis carinii, Toxoplasma gondii, and Mycobacterium avium dihydrofolate reductase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

Type II NADH dehydrogenase inhibitor 1-hydroxy-2-dodecyl-4(1H)quinolone leads to collapse of mitochondrial inner-membrane potential and ATP depletion in Toxoplasma gondii

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

The Toxoplasma gondii type-II NADH dehydrogenase TgNDH2-I is inhibited by 1-hydroxy-2-alkyl-4(1H)quinolones.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

Cysteine protease inhibitors block Toxoplasma gondii microneme secretion and cell invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

Interaction of sulfonamide and sulfone compounds with Toxoplasma gondii dihydropteroate synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

Respiration and oxidative phosphorylation in the apicomplexan parasite Toxoplasma gondii

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

Thiazole, oxadiazole, and carboxamide derivatives of artemisinin are highly selective and potent inhibitors of Toxoplasma gondii

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

Structure-activity studies of some berberine analogs as inhibitors of Toxoplasma gondii

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

ToxoDB: an integrated Toxoplasma gondii database resource

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

The Protein Data Bank and structural genomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

Genomic-scale prioritization of drug targets: the TDR Targets database

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

Recognition and characterization of stage-specific oocyst/sporozoite antigens of Toxoplasma gondii by human antisera

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

Apicomplexan gliding motility and host cell invasion: overhauling the motor model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

Building the perfect parasite: cell division in apicomplexa

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

The moving junction of apicomplexan parasites: a key structure for invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

Invasion by Toxoplasma gondii establishes a moving junction that selectively excludes host cell plasma membrane proteins on the basis of their membrane anchoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

Molecular partitioning during host cell penetration by Toxoplasma gondii.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

Structure-based design of novel small-molecule inhibitors of Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

Rapid discovery of inhibitors of Toxoplasma gondii using hybrid structure-based computational approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

Structure of the MTIP-MyoA complex, a key component of the malaria parasite invasion motor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

Evaluation of comparative protein modeling by MODELLER

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

A small-molecule approach to studying invasive mechanisms of Toxoplasma gondii

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

A small-molecule inhibitor of T. gondii motility induces the posttranslational modification of myosin light chain-1 and inhibits myosin motor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

Identification of proteases that regulate erythrocyte rupture by the malaria parasite Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

Chemical genetic screen identifies Toxoplasma DJ-1 as a regulator of parasite secretion, attachment, and invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

Identification of the moving junction complex of Toxoplasma gondii: a collaboration between distinct secretory organelles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

The rhoptry neck protein RON4 re-localizes at the moving junction during Toxoplasma gondii invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

Export of a Toxoplasma gondii rhoptry neck protein complex at the host cell membrane to form the moving junction during invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

Novel components of the Apicomplexan moving junction reveal conserved and coccidia-restricted elements

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

Plasmodium falciparum AMA1 binds a rhoptry neck protein homologous to TgRON4, a component of the moving junction in Toxoplasma gondii

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

Apical membrane antigen 1 plays a central role in erythrocyte invasion by Plasmodium species

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

Conditional expression of Toxoplasma gondii apical membrane antigen-1 (TgAMA1) demonstrates that TgAMA1 plays a critical role in host cell invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

Toxoplasma gondii homologue of plasmodium apical membrane antigen 1 is involved in invasion of host cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

Specificity of the protective antibody response to apical membrane antigen 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

Structure of an IgNAR-AMA1 complex: targeting a conserved hydrophobic cleft broadens malarial strain recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

Cross-reactivity studies of an anti-Plasmodium vivax apical membrane antigen 1 monoclonal antibody: binding and structural characterisation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

Binding hot spot for invasion inhibitory molecules on Plasmodium falciparum apical membrane antigen 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

Peptide inhibitors of the malaria surface protein, apical membrane antigen 1: identification of key binding residues

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

Rapid optimization of a peptide inhibitor of malaria parasite invasion by comprehensive N-methyl scanning

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

Host cell invasion by apicomplexan parasites: insights from the co-structure of AMA1 with a RON2 peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

The RON2-AMA1 interaction is a critical step in moving junction-dependent invasion by apicomplexan parasites

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

Novel N-benzoyl-2-hydroxybenzamide disrupts unique parasite secretory pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

Proteases as regulators of pathogenesis: examples from the Apicomplexa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

A novel benzodioxole-containing inhibitor of Toxoplasma gondii growth alters the parasite cell cycle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

Effects of Toxoplasma gondii infection on the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

A history of studies that examine the interactions of Toxoplasma with its host cell: Emphasis on in vitro models

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

Discovery of Potent and Selective Inhibitors of CDPK1 from C. parvum and T. gondii

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

Multiple Determinants for Selective Inhibition of Apicomplexan Calcium-Dependent Protein Kinase CDPK1

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

Development of Toxoplasma gondii calcium-dependent protein kinase 1 (TgCDPK1) inhibitors with potent anti-toxoplasma activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

Toxoplasma gondii calcium-dependent protein kinase 1 is a target for selective kinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

Use of the kinase inhibitor analog 1NM-PP1 reveals a role for Toxoplasma gondii CDPK1 in the invasion step

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

Targeted disruption of Toxoplasma gondii serine protease inhibitor 1 increases bradyzoite cyst formation in vitro and parasite tissue burden in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

1-(Fluoroalkylidene)-1,1-bisphosphonic acids are potent and selective inhibitors of the enzymatic activity of Toxoplasma gondii farnesyl pyrophosphate synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

Synthesis and biological evaluation of new 2-alkylaminoethyl-1,1-bisphosphonic acids against Trypanosoma cruzi and Toxoplasma gondii targeting farnesyl diphosphate synthase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

Synthesis and biological evaluation of 2-alkylaminoethyl-1,1-bisphosphonic acids against Trypanosoma cruzi and Toxoplasma gondii targeting farnesyl diphosphate synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

Inhibition of Toxoplasma gondii growth by pyrrolidine dithiocarbamate is cell cycle specific and leads to population synchronization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

Activity of the histone deacetylase inhibitor FR235222 on Toxoplasma gondii: inhibition of stage conversion of the parasite cyst form and study of new derivative compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

Scriptaid and suberoylanilide hydroxamic acid are histone deacetylase inhibitors with potent anti-Toxoplasma gondii activity in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

Identification and Development of Novel Inhibitors of Toxoplasma gondii Enoyl Reductase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

Structure-activity relationships of carbocyclic 6-benzylthioinosine analogues as subversive substrates of Toxoplasma gondii adenosine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

The P-glycoprotein inhibitor GF120918 modulates Ca2+-dependent processes and lipid metabolism in Toxoplasma gondii

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

Dynamin inhibitor impairs Toxoplasma gondii invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

Toxoplasma gondii Cathepsin L Is the Primary Target of the Invasion-inhibitory Compound Morpholinurea-leucyl-homophenyl-vinyl Sulfone Phenyl

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

The cathepsin L of Toxoplasma gondii (TgCPL) and its endogenous macromolecular inhibitor, toxostatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

Inhibition of Toxoplasma gondii and Plasmodium falciparum infections in vitro by NSC3852, a redox active antiproliferative and tumor cell differentiation agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

Anti-infectives targeting the isoprenoid pathway of Toxoplasma gondii

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

Drugs designed to inhibit human p38 mitogen-activated protein kinase activation treat Toxoplasma gondii and Encephalitozoon cuniculi infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

Fluorine-containing aryloxyethyl thiocyanate derivatives are potent inhibitors of Trypanosoma cruzi and Toxoplasma gondii proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

Quinoline derivative MC1626, a putative GCN5 histone acetyltransferase (HAT) inhibitor, exhibits HAT-independent activity against Toxoplasma gondii

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

Selective anti-Toxoplasma gondii activities of azasterols

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

Functional analysis of Toxoplasma gondii protease inhibitor 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

Proteasome inhibitors block intracellular growth and replication of Toxoplasma gondii

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

Identification of small-molecule inhibitors of nucleoside triphosphate hydrolase in Toxoplasma gondii

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

In vitro effects of gliotoxin, a natural proteasome inhibitor, on the infectivity and proteolytic activity of Toxoplasma gondii.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

The carboxyltransferase activity of the apicoplast acetyl-CoA carboxylase of Toxoplasma gondii is the target of aryloxyphenoxypropionate inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

Growth of Toxoplasma gondii is inhibited by aryloxyphenoxypropionate herbicides targeting acetyl-CoA carboxylase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

Evaluation of two inhibitors of invasion: LY311727 [3-(3-acetamide-1-benzyl-2-ethyl-indolyl-5-oxy)propane phosphonic acid] and AEBSF [4-(2-aminoethyl)-benzenesulphonyl fluoride] in acute murine toxoplasmosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

Benzimidazole-4,7-diones as inhibitors of protozoal (Toxoplasma gondii) purine nucleoside phosphorylase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

Triclosan inhibits the growth of Plasmodium falciparum and Toxoplasma gondii by inhibition of apicomplexan Fab I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

Structure-activity relationships for the binding of ligands to xanthine or guanine phosphoribosyl-transferase from Toxoplasma gondii

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

Some phosphonic acid analogs as inhibitors of pyrophosphate-dependent phosphofructokinase, a novel target in Toxoplasma gondii

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

Structure-activity relationship of ligands of uracil phosphoribosyltransferase from Toxoplasma gondii

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

Solution structure and dynamics of ADF from Toxoplasma gondii

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

Crystal structure of adenosine kinase from Toxoplasma gondii at 1.8 Å resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

Structural Characterization of Apical Membrane Antigen 1 (AMA1) from Toxoplasma gondii

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

Structural Characterization of the Bradyzoite Surface Antigen (BSR4) from Toxoplasma gondii, a Unique Addition to the Surface Antigen Glycoprotein 1-related Superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

Structures of apicomplexan calcium-dependent protein kinases reveal mechanism of activation by calcium

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

Crystal Structure of Toxoplasma gondii Porphobilinogen Synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

Studies ofToxoplasma gondiiandPlasmodium falciparumenoyl acyl carrier protein reductase and implications for the development of antiparasitic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

Crystal structures of Toxoplasma gondii HGXPRTase reveal the catalytic role of a long flexible loop

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

Structure-Based Analysis of Toxoplasma gondii Profilin: A Parasite-Specific Motif Is Required for Recognition by Toll-Like Receptor 11

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

Structure of Toxoplasma gondii LDH1: active-site differences from human lactate dehydrogenases and the structural basis for efficient APAD+ use

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

A novel galectin-like domain from Toxoplasma gondii micronemal protein 1 assists the folding, assembly, and transport of a cell adhesion complex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

Structural insights into microneme protein assembly reveal a new mode of EGF domain recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

Galactose Recognition by the Apicomplexan Parasite Toxoplasma gondii

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

Structure of the micronemal protein 2 A/I domain fromToxoplasma gondii

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

Structural insight into activation mechanism of Toxoplasma gondii nucleoside triphosphate diphosphohydrolases by disulfide reduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

Structural genomics of protein phosphatases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

Crystal structures of Toxoplasma gondii pterin-4a-carbinolamine dehydratase and comparisons with mammalian and parasite orthologues

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

The crystal structure of Toxoplasma gondii pyruvate kinase 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

Novel structural and regulatory features of rhoptry secretory kinases in Toxoplasma gondii

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

ROP2 from Toxoplasma gondii: a virulence factor with a protein-kinase fold and no enzymatic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

A Conserved Non-canonical Motif in the Pseudoactive Site of the ROP5 Pseudokinase Domain Mediates Its Effect on Toxoplasma Virulence

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

Structural and Functional Characterization of SporoSAG: A SAG2-RELATED SURFACE ANTIGEN FROM TOXOPLASMA GONDII

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

Genome-scale protein expression and structural biology of Plasmodium falciparum and related Apicomplexan organisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

Toxofilin from Toxoplasma gondii forms a ternary complex with an antiparallel actin dimer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

Crystal structures of Toxoplasma gondii uracil phosphoribosyltransferase reveal the atomic basis of pyrimidine discrimination and prodrug binding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

Myosin A tail domain interacting protein (MTIP) localizes to the inner membrane complex of Plasmodium sporozoites

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.729036

10.1517/17460441.2012.729036

21 January 2018

Identifiers

DOI

1 reference

27 August 2017

1 reference